IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2023 Holdings

Filed 2023-05-15 | 11 holdings | $781.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alkermes PLC(ALKS)SHSG01767105$252.7M8,964,64032.3%
Biogen Inc(BIIB)COM09062X103$178.8M643,00022.9%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$172.4M16,390,00022.1%
Innoviva Inc(INVA)COM45781M101$74.4M6,614,0009.5%
Gilead Sciences Inc(GILD)COM375558103$70.5M850,0009.0%
Mersana Therapeutics IncCOM59045L106$15.6M3,800,0002.0%
Amarin Corp PLCSPONS ADR NEW023111206$7.4M4,910,0000.9%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$6.5M775,0000.8%
VOR Biopharma IncCOM929033108$3.3M618,0000.4%
Regulus Therapeutics Inc(RGLS)COM75915K309$156.9K185,1830.0%
Pear Therapeutics IncCLASS A COM704723105$127.6K500,3560.0%